RECOMBINANT ADENOVIRUS TYPE 5 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN (CANSINO BIOLOGICS)
COVID-19
Seventh Medical Center of PLA General HospitalvaccinePhase 3Active
BBB
77/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 68/ 100
- Competitive Position
- 95/ 100
Competitive context
31 Active assets in the COVID-19 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Genotropin ClinAmygate | Phase 4 | BB |
cc-220 Nguyen Thi Trieu, MD | Phase 4 | BB |
Tocilizumab National Cancer Institute (NCI) | Phase 3 | BB |
Genotropin ClinAmygate | Phase 4 | BB |
Oxygen Jay C. Buckey Jr. | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →